OVARIAN CANCER: CLINICAL EXOME PANEL (Sec. & CNVs) – 31 genes
LabGenetics
Delivery time
3-4 weeks
Sample
Blood
The Hereditary Ovarian Cancer Panel is designed to detect germline mutations that increase the risk of epithelial ovarian carcinoma, including familial and syndromic forms. It analyzes genes involved in homologous recombination DNA repair and in hereditary cancer predisposition syndromes, such as BRCA1/2, Lynch (MLH1, MSH2, MSH6, PMS2, EPCAM), Cowden (PTEN), and Peutz-Jeghers (STK11). The identification of pathogenic variants in these genes allows for targeted surveillance, surgical prophylaxis, and the use of targeted therapies such as PARP inhibitors. Genes analyzed: BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D, MLH1, TP53, and others. You can obtain the complete list of analyzed genes by contacting Genotica.